Cumberland Pharmaceuticals (CPIX) Minority Interest (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Minority Interest of -$333512.0 for Q1 2026, down 5.41% on a YoY basis from -$352579.5 in Q1 2025, and up 0.77% sequentially from -$336100.0 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Minority Interest (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 17 years of Minority Interest data on file, last reported at -$333512.0 in Q1 2026.
- For the quarter ending Q1 2026, Minority Interest fell 5.41% year-over-year to -$333512.0; the trailing twelve-month figure through Mar 2026 stood at -$333512.0 (down 5.41% YoY), and the FY2025 full-year result was -$336100.0, down 9.29% from the prior year.
- Minority Interest improved to -$333512.0 in Q1 2026, from -$336100.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of -$229508.0 in Q1 2022 to a low of -$343572.0 in Q4 2023.
- A 5-year average of -$306871.5 and a median of -$312024.0 in 2023 frame the typical range for Minority Interest.
- Across the five-year window, Minority Interest sank 79.11% in 2022 and advanced 10.49% in 2024, its largest moves.
- Tracing CPIX's Minority Interest over 5 years: stood at -$292126.0 in 2022, then slipped by 17.61% to -$343572.0 in 2023, then climbed by 10.49% to -$307517.0 in 2024, then retreated by 9.29% to -$336100.0 in 2025, then advanced by 0.77% to -$333512.0 in 2026.
- Business Quant data shows CPIX's Minority Interest at -$333512.0 in Q1 2026, -$336100.0 in Q4 2025, and -$319150.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -333,512.00 |
| Dec 31, 2025 | -336,100.00 |
| Sep 30, 2025 | -319,150.00 |
| Jun 30, 2025 | -310,868.00 |
| Mar 31, 2025 | -316,401.00 |
| Dec 31, 2024 | -307,517.00 |
| Sep 30, 2024 | -309,694.00 |
| Jun 30, 2024 | -316,806.00 |
| Mar 31, 2024 | -299,781.00 |
| Dec 31, 2023 | -343,572.00 |
| Sep 30, 2023 | -335,991.00 |
| Jun 30, 2023 | -322,070.00 |
| Mar 31, 2023 | -312,024.00 |
| Dec 31, 2022 | -292,126.00 |
| Sep 30, 2022 | -273,141.00 |
| Jun 30, 2022 | -258,554.00 |
| Mar 31, 2022 | -229,508.00 |
| Dec 31, 2021 | -212,328.00 |
| Sep 30, 2021 | -175,767.00 |
| Jun 30, 2021 | -144,352.00 |